Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin

Autor: Pujol, J.-L. *, Breton, J.-L., Gervais, R., Rebattu, P., Depierre, A., Morère, J.-F., Milleron, B., Debieuvre, D., Castéra, D., Souquet, P.-J., Moro-Sibilot, D., Lemarié, E., Kessler, R., Janicot, H., Braun, D., Spaeth, D., Quantin, X., Clary, C.
Zdroj: In Annals of Oncology April 2005 16(4):602-610
Databáze: ScienceDirect